VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹16 Cr | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹16 Cr |
Mar2024 | ₹11 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹-0.68 Cr |
Mar2021 | ₹3.63 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | 42.73 | |
Mar2024 | ₹11 Cr | 2.54 | |
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-0.68 Cr | Negative | |
Mar2021 | ₹3.63 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹617.2 Cr | -0.6% | -7.7% | 34.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -0.6% |
-7.7% |
34.7% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses